Fundraising Fox

Unicycive Therapeutics

NASDAQ: UNCY

Los Altos, US · Founded 2016 · Delaware corporation · 23 employees on LinkedIn

Biotech

Founders & leadership

Unicycive Therapeutics was founded in 2016 by Shalabh Gupta.

SG
Shalabh GuptainFounder
SL
Sandeep LaumasNamed on SEC filing
JR
John RyanNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$81.7M disclosed across 5 rounds · 2019–2024

▶$50MraisedMar 2024 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John RyanDirector
  • Gaurav AggarwalDirector
  • Sara Kenkare-MitraDirector
  • Sandeep LaumasDirector
  • John TownsendExecutive Officer
  • Shalabh GuptaExecutive Officer, Director
Offering amount
$50M
Amount sold
$50M
Sales commissions
$3.5M
Placement agents
Leerink Partners LLC, Piper Sandler & Co.
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$30.2MraisedMar 2023 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandeep LaumasDirector
  • John TownsendExecutive Officer
  • John RyanDirector
  • Shalabh GuptaExecutive Officer, Director
  • Brigitte SchillerDirector
  • Gaurav AggarwalDirector
Offering amount
$30.2M
Amount sold
$30.2M
Sales commissions
$1.6M
Placement agents
EF Hutton, division of Benchmark Investments LLC
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$604.1KraisedJun 2020 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John RyanDirector
  • Shalabh GuptaExecutive Officer
  • Sandeep LaumasDirector
Offering amount
$604.1K
Amount sold
$604.1K
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$527KraisedAug 2019 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shalabh GuptaExecutive Officer
  • John RyanDirector
  • Sandeep LaumasDirector
Offering amount
$527K
Amount sold
$527K
Minimum investment
$50K
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$420KraisedMar 2019 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Shalabh GuptaExecutive Officer, Director
  • Sandeep LaumasDirector
  • John RyanDirector
Offering amount
$420K
Amount sold
$420K
Minimum investment
$50K
First sale
Feb 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who founded Unicycive Therapeutics?
Unicycive Therapeutics was founded by Shalabh Gupta in 2016.
How much funding has Unicycive Therapeutics raised?
Unicycive Therapeutics has disclosed $81.7M raised across 5 rounds.
Where is Unicycive Therapeutics headquartered?
Unicycive Therapeutics is headquartered in Los Altos, US.